Esterline CMC Electronics' Flight Management Systems and

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Esterline CMC Electronics' Flight Management Systems and GPS Landing Systems Selected by Airbus Helicopters and French DGA for Securite Civile EC145 Retrofit Program

FARNBOROUGH, UNITED KINGDOM--(Marketwired - Jul 11, 2016) - Farnborough International Airshow -- Esterline CMC Electronics (CMC) ( NYSE : ESL ) is pleased to announce that the CMA-9000 Flight Management System (FMS) and CMA-5024 GPS Landing System have been selected by the French Direction générale de l'armement (DGA) and by Airbus Helicopters, to upgrade the Sécurité Civile fleet of EC145 helicopters. The 35 helicopters that will be upgraded are deployed on Sécurité Civile bases in France and the French Overseas Territories and are used for search and rescue, emergency medical services (EMS), surveillance and law enforcement. This retrofit program will improve the operational mission performance of the EC145 helicopters in all weather conditions and enable compliance with the newest civil airspace regulations for performance based navigation (PBN), ADS-B and SBAS-enabled LPV approaches.

Jim Palmer, Vice President, Products, Navigation Solutions, said: "We are very proud that the French DGA and Airbus Helicopters have selected the CMA-9000 and CMA-5024 to augment the capabilities of these advanced multi-role helicopters. The upgraded EC145s will be able to leverage the CMA-9000's unique combination of civil certification, advanced tactical functions and radio management capability to operate both on specialized missions and in civil airspace."

The CMA-9000 is a field-proven, highly integrated and flexible solution that is optimized for helicopter operations. It provides flight management and multi-sensor navigation throughout all phases of flight, radio management and many specialized functions that help reduce pilot workload during mission-critical applications such as Search and Rescue (SAR) and Emergency Medical Services (EMS). The CMA-9000 supports both military and civil navigation modes, with compliance to the latest standards for Required Navigation Performance (RNP) and Satellite Based Augmentation System (SBAS) approaches. The integrated radio management system offers savings in terms of size, weight, power and cost on the helicopter. Night Vision Goggle (NVG) capability enables night-time operations for police, SAR and Emergency Medical Service operators, making the CMA-9000 the FMS of choice for demanding helicopter applications.

CMC's IntegriFlight™ CMA-5024 GPS Landing System Sensor meets the requirements for an Instrument Flight Rules, civil certified Global Navigation Satellite System (GNSS). The European Geostationary Navigation Overlay Service (EGNOS), a component of the international Satellite Based Augmentation System (SBAS), augments GPS to provide an extremely accurate navigation solution that will support all flight operations from en route through Localizer Performance with Vertical Guidance (LPV) CAT-1 equivalent approach. The CMA-5024 is compliant with and completely supports EGNOS/SBAS, from departure, en-route navigation, and all EGNOS/SBAS LPV Precision Approaches, and complies with published Communication Navigation Surveillance/Air Traffic Management (CNS/ATM) navigational mandates. The CMA-5024 is provisioned for growth to GBAS with a built-in VHF Data Broadcast (VDB) receiver debuting in the summer of 2017.

The CMC Electronics (CMC) brand within Esterline Avionics Systems ( www.esterline.com/avionicssystems ) has achieved an international reputation for innovation and excellence in the design and manufacture of electronics products for the military and commercial aviation markets. The company's focus is on delivering innovative cockpit systems integration and avionics solutions to its customers worldwide. CMC is a wholly owned subsidiary of Esterline Corporation ( NYSE : ESL ) www.esterline.com , a specialized aerospace and defense company headquartered in Bellevue, WA, that employs over 13,000 people worldwide.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 62

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 271

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 718

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 135

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 255

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 410

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 105

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 325

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 139

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 190

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Kearney's 2025 Global Cities Report Insights

Updated Category News Views 654

Global Cities Adapt to New Challenges and Emergence Global cities hold steady at the top as new hubs surge forward Top cities reaffirm their dominance in the Global Cities Index, showcasing remarkable resilience amidst global changes and uncertainties. The Global Cities Outlook indicates a noticeable shift as traditional leaders face turbulence, while emerging Gulf and...

Continue Reading
Vacca Family Law Group Enhances Support for Peaceful Divorce

Updated Category News Views 255

Empowering Families Through Non-Adversarial Divorce Solutions Families navigating the challenging process of separation now have renewed access to considerate and non-confrontational divorce options. Vacca Family Law Group has recently welcomed Attorney and Mediator Wendy Reimer, who brings nearly two decades of experience in family law and a strong background in...

Continue Reading
Ingredion Delivers Impressive Q3 Results, Upgrades Outlook

Updated Category News Views 55

Ingredion's Strong Performance in the Third Quarter Ingredion Incorporated (NYSE: INGR) has reported remarkable results for the third quarter of 2024, showcasing a noteworthy surge in both operating income and earnings per share (EPS). The global leader in ingredient solutions for the food and beverage industry achieved a stunning 26% increase in reported operating income...

Continue Reading
Insight into Learning Technologies Group Plc's Disclosure Mechanism

Updated Category News Views 193

Understanding the Public Opening Position Disclosure Process In the complex world of financial securities, understanding the disclosure requirements can feel daunting. However, the process outlined by the Takeover Code, particularly Rule 8.3, provides a structured approach for individuals and entities holding significant interests in relevant securities. This rule is...

Continue Reading
Avidity Biosciences Set to Inspire with Latest Presentations

Updated Category News Views 191

Avidity Biosciences' Key Presentations at the MDA Conference Avidity Biosciences, Inc. (Nasdaq: RNA), a pioneer in RNA therapeutics, is poised to make a significant impact at the upcoming Clinical and Scientific Conference organized by the Muscular Dystrophy Association (MDA). The event will showcase the latest advancements in the field and highlight groundbreaking...

Continue Reading